Form 4: Senseonics Director Acquires Shares in Lieu of Fees

Senseonics Holdings director Douglas A. Roeder acquired 31,183 shares of common stock in lieu of quarterly retainer fees.

Summary

• Director Douglas A. Roeder acquired 31,183 shares of Senseonics Holdings common stock on January 2, 2025.
• The shares were issued as compensation in lieu of quarterly retainer fees.
• The value of the shares was calculated based on the closing price of Senseonics common stock on January 2, 2025, which was $0.473 per share.
• The total value of the shares issued was $14,749.56.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders. There are no indications of any negative or concerning issues.

Positives

• The acquisition of shares by a director demonstrates alignment of interests with shareholders.
• The use of stock in lieu of cash for director compensation can be seen as a positive for the company's cash flow.

Industry Context

This is a routine transaction related to director compensation and is common practice for publicly traded companies. It does not indicate any specific trend or event in the medical device industry.

Comparison to Industry Standards

• Many publicly traded companies use stock-based compensation for directors to align their interests with shareholders.
• The practice of issuing shares in lieu of cash fees is a common method of compensation in the industry.
• The value of the shares issued is consistent with typical director compensation practices.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.
• The use of stock instead of cash for compensation can be seen as a positive for the company's cash flow.

Key Dates

Keywords

Senseonics, Director, Stock Acquisition, Compensation, Equity, Form 4, Insider Trading